Ipamorelin
Lyophilized *MUST BE RECONSTITUTED* Ipamorelin is a selective growth hormone secretagogue.
Lyophilized *MUST BE RECONSTITUTED* Ipamorelin is a selective growth hormone secretagogue.

Ipamorelin - 10mg
Lyophilized *MUST BE RECONSTITUTED* Ipamorelin is a selective growth hormone secretagogue.
$159/moPeople also buy
CJC-1295 - 5mg (NO DAC)
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a growth hormone-releasing hormone (GHRH) analogue that has been studied for its potential role in stimulating the natural, pulsatile release of growth hormone. For research use only.

CJC-1295 / Ipamorelin
This blend combines CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective growth hormone secretagogue. Together they have been studied for their potential to support the body's natural release of growth hormone. For research use only.

Tesamorelin / CJC-1295 (No DAC) / Ipamorelin
This blend combines Tesamorelin and CJC-1295 (No DAC) — both GHRH analogues — with the growth hormone secretagogue Ipamorelin, studied together for their potential to support the natural release of growth hormone. For research use only.

Tesamorelin / Ipamorelin
This blend pairs Tesamorelin, a GHRH analogue, with Ipamorelin, a selective growth hormone secretagogue, studied together for their potential role in supporting the natural release of growth hormone. For research use only.

Tesamorelin
Lyophilized *MUST BE RECONSTITUTED* Tesamorelin is known for its potential to stimulate the body’s natural production of growth hormon

Sermorelin Capsules - 1mg
Sermorelin 1mg Capsules This compound is often explored for its potential role in growth hormone–related pathways and endocrine function in

MK-677 Capsules - 20mg
MK-677 20mg Capsules This compound is commonly studied for its potential influence on growth hormone pathways, body composition, and metabol

Sermorelin - 10mg
10mg – Lyophilized *MUST BE RECONSTITUTED* Sermorelin is a synthetic peptide that has been extensively studied for its role in stimula
References
- Ipamorelin - Peptide Center guide
- Ipamorelin, the first selective growth hormone secretagogueEuropean journal of endocrinology, 1998
- The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanismPhysiology & behavior, 2024
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Resear, 1999
- Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitroHistology and histopathology, 2002
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersPharmaceutical research, 1999
- Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patientsInternational journal of colorectal disease, 2014
Ready to start with Ipamorelin?
Take our eligibility quiz to see if this treatment is right for you.
Start Intake